✦ LIBER ✦

The advantages of a gonadotropin releasing hormone agonist (leuprolide acetate) in conjunction with gonadotropins for controlled ovarian hyperstimulation in IVF and GIFT cycles

✍ Scribed by J. F. Kerin

Publisher: Springer
Year: 1989
Tongue: English
Weight: 496 KB
Volume: 246
Category: Article
ISSN: 0003-9128
DOI: 10.1007/bf00935852

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A controlled ovarian hyperstimulation re

A controlled ovarian hyperstimulation regimen involving intermittent gonadotropin administration with a “short” protocol of gonadotropin releasing hormone agonist for in vitro fertilization

✍ Nobuhiko Suganuma; Shin-Ichiro Tsukahara; Takeshi Kitagawa; Madoka Furuhashi; Yo 📂 Article 📅 1996 🏛 Springer US 🌐 English ⚖ 553 KB

The use of long-acting gonadotropin-rele

The use of long-acting gonadotropin-releasing hormone agonist (GnRH-a; decapeptyl) and gonadotropins versus short-acting GnRH-a (Buserelin) and gonadotropins before and during ovarian stimulation for in vitro fertilization (IVF)

✍ Yael Gonen; Martha Dirnfeld; Shlomit Goldman; Mara Koifman; Haim Abramovici 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 531 KB

Comparison of ovarian stimulation regime

Comparison of ovarian stimulation regimens for in vitro fertilization (IVF) with and without a gonadotropin-releasing hormone (GnRH) agonist: Results of a randomized study

✍ A. Berg Van De-Helder; F. M. Helmerhorst; A. Blankhart; R. Brand; C. Waegemaeker 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 445 KB

Incorporation of a GnRH agonist, leuprol

Incorporation of a GnRH agonist, leuprolide acetate, into regimens with exogenous gonadotropins to produce ovarian stimulation and ovulation in the nonpregnant squirrel monkey

✍ Thomas J. Kuehl; Thomas W. Davis; Clayton Young; Patty Nunez; Melissa R. Robinso 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB 👁 2 views

This study was designed to measure the effects of variations in the length of pretreatment with a GnRH agonist, leuprolide acetate (LA), on subsequent follicular development and ovulation. The hypothesis was that the duration of LA suppression of pituitary function does not adversely affect ovarian

Ovarian hyperstimulation syndrome follow

Ovarian hyperstimulation syndrome following the sole administration of injectable gonadotropin-releasing hormone agonist (triptorelin) for the pituitary down-regulation and in vitro fertilization treatment: report of two cases

✍ Hussein S. Qublan; Zakarya Beni-Merei; Mohamad Megdadi; Gassan Al-Quraan 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 145 KB

The initial flare-up induced by gonadotr

The initial flare-up induced by gonadotropin releasing hormone agonist May serve as a predictor of ovarian response in the current IVF-ET treatment cycle in normogonadotropic women aged 40–48 years

✍ Ori M. Avrech; Moshe Royburt; Gad Sabah; Zvi Zukerman; Haim Pinkas; Shoshana Ami 📂 Article 📅 1996 🏛 Springer US 🌐 English ⚖ 605 KB